Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform.

Document Cited in Related
Vincent

M2 EQUITYBITES-January 6, 2022-Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform

(C)2022 M2 COMMUNICATIONS http://www.m2.com

Canada-based integrated CRO/CDMO Altasciences has closed the acquisition of Midwest, US-based preclinical CRO Sinclair Research, the company said.

Complementing existing locations on the East and West Coast, the new site will facilitate even greater access to Altasciences' preclinical services across the USA.

With over 80 animal rooms, Sinclair Research is a large nonclinical CRO in the USA., providing IND and NDA-enabling toxicology and safety pharmacology services.

Built on more than 50 years of experience, Sinclair Research provides services to support biopharmaceutical, animal health, and medical device development programs.

Fredrikson and Byron P.A. and Goodwin Procter LLP served as legal advisors to Altasciences on the transaction.

Fairmount Partners acted as exclusive financial advisors to Sinclair Research, and Troutman Pepper acted as legal counsel.

Altasciences is an integrated drug development...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT